StockDrifts LogoStockDrifts

Genomic tree 228760

Company
지노믹트리Genomic tree
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2026-05-20

Genomic tree (228760) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Genomic tree is dated 2024-07-03; the most recent is 2026-05-20. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-05-20BUY자사주상여금
이정철
Lee Jeong-cheol
moving1.0K₩13,530+1.2%₩14M ($9K)
2026-05-20BUY자사주상여금
이홍선
Lee Hong-seon
Managing Director2.0K₩13,530+1.2%₩27M ($19K)
2026-05-20BUY자사주상여금
이용운
Lee Yong-un
Managing Director2.0K₩13,530+1.2%₩27M ($19K)
2026-05-20BUY자사주상여금
오태정
Taejeong Oh
Managing Director2.0K₩13,530+1.2%₩27M ($19K)
2026-01-08BUY자사주상여금
오태정
Taejeong Oh
Managing Director3.5K₩28,750-24.0%₩101M ($70K)
2026-01-08BUY자사주상여금
이정철
Lee Jeong-cheol
moving1.8K₩28,750-24.0%₩50M ($35K)
2026-01-08BUY자사주상여금
이홍선
Lee Hong-seon
Managing Director3.5K₩28,750-24.0%₩101M ($70K)
2026-01-08BUY자사주상여금
이용운
Lee Yong-un
Managing Director3.5K₩28,750-24.0%₩101M ($70K)
2025-06-11BUY자사주상여금
이정철
Lee Jeong-cheol
moving1.5K₩13,010+68.0%₩20M ($14K)
2025-06-11BUY자사주상여금
오태정
Taejeong Oh
Managing Director3.0K₩13,010+68.0%₩39M ($27K)
2025-06-11BUY자사주상여금
이용운
Lee Yong-un
Managing Director1.5K₩13,010+68.0%₩20M ($14K)
2025-06-11BUY자사주상여금
이홍선
Lee Hong-seon
Managing Director1.5K₩13,010+68.0%₩20M ($14K)
2024-07-03BUY자사주상여금
이홍선
Lee Hong-seon
Managing Director1.5K₩23,400-6.6%₩35M ($24K)
2024-07-03BUY자사주상여금
이용운
Lee Yong-un
Managing Director1.5K₩23,400-6.6%₩35M ($24K)

Frequently asked questions

Who has been buying Genomic tree stock?
0 distinct insiders have filed 0 disclosed insider purchases in Genomic tree (228760), most recently on 2026-05-20. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Genomic tree have?
Genomic tree has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-07-03 to 2026-05-20.
Where does StockDrifts get Genomic tree insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Genomic tree. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.